Key Highlights

  • Universal Health Services (NYSE:UHS) reports third-quarter results after the close on Tuesday, October 27, 2026, with consensus adjusted earnings of USD 5.15 per share, against USD 5.98 reported for the second quarter.
  • Management lowered its 2026 adjusted earnings forecast to USD 22.28 to USD 23.65 per share from USD 22.64 to USD 24.52, a cut of 2.6% at the midpoint, citing operating trends and Medicaid payment changes.
  • The second quarter included a net pre-tax benefit of about USD 72 million from a Florida Medicaid directed payment, net of higher liability reserves, which flatters the comparison with USD 5.15.
  • Results cannot be known in advance, so admissions, pricing and the refreshed full-year range are the figures that should decide the reaction.

Universal Health Services (NYSE:UHS) Setup: A Lowered Forecast and a Lower Bar

Universal Health Services (NYSE:UHS) operates acute care hospitals and behavioural health facilities, and it reports third-quarter results after the close on Tuesday, October 27, 2026. Consensus adjusted earnings are USD 5.15 per share. In the company's release of Monday, July 27, 2026, second-quarter net revenues rose 8.3% to USD 4.638 billion and diluted earnings were USD 5.98 per share. Adjusted EBITDA net of non-controlling interests, a profit measure after deducting partners' shares, was USD 677.9 million, a margin of 14.6% against 15.0% a year earlier. The revised 2026 forecast calls for net revenues of USD 18.501 billion to USD 18.762 billion. The earlier call followed the release at 9:00 a.m. ET the next day, so a call on Wednesday, October 28 is likely.

How Volumes, Pricing and Medicaid Payments Move Universal Health Services (NYSE:UHS)

Hospital earnings depend on admissions, the price paid per admission and supplemental Medicaid payments. In the second quarter, same-facility acute care adjusted admissions rose 2.9% and revenue per adjusted admission rose 3.0%, while behavioural health adjusted admissions rose 0.5% and revenue per adjusted admission rose 7.1%. The forecast adds no further Florida benefit beyond September 30, 2025, because federal approval of the larger programme for later periods is pending, which is a potential upside. First-half adjusted earnings were USD 11.60 per share, so by simple arithmetic the revised forecast implies USD 10.68 to USD 12.05 for the second half, and consensus of USD 5.15 for the third quarter sits within that range.

Risks and What to Watch

The bull case is adjusted earnings above USD 5.15, firm acute admissions and a narrowed forecast that holds the midpoint, with any approval of further Florida payments an added positive. That would suggest the July cut was cautious, and the shares could rise. The bear case is a shortfall, a further reduction in the forecast, higher professional liability reserves or weaker behavioural health volumes, which could lead to a fall because the July cut already lowered confidence. Investors should watch adjusted admissions, labour and reserve costs, Medicaid supplemental payment news and the range for full-year adjusted earnings. The Federal Reserve decides on Wednesday, October 28, 2026, after raising rates on Wednesday, September 16, 2026, which bears on the group's interest costs.

Where Things Stand

The answer is that Universal Health Services (NYSE:UHS) faces a bar of USD 5.15 per share that reflects the lowered forecast, so volumes, pricing and the Medicaid outlook matter more than a small beat. Management needs to hold the USD 22.28 to USD 23.65 range. The next catalysts are the release after the close on Tuesday, October 27, 2026, a likely call on Wednesday, October 28, 2026 and the Federal Reserve decision the same day. Estimates and forecasts are not guarantees, and this is not investment advice.